MTAP and cancer: Having identified MTAP-WT cells’ presence (i.e., stromal cells, which are predominantly myeloid in GBM) inside MTAP-deleted tumors, we hypothesized that excess MTA secreted from homozygous MTAP-deleted cancer cells may be metabolized by non-malignant MTAP-expressing cells present inside tumors.